The 3rd Annual Philippines HR Workplace Summit 2025, organized by Escom Events, is set to take place on November 6, 2025, at ...

Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that five abstracts ? one oral and four poster ...

Free cancer support services are available for cancer patients and survivors living on Guam and members of their support team ...

Konecta, a global leader in Customer Experience (CX) transformation and digital operations, today announced a strategic alliance with CrewAI, the pioneering multi-agent orchestration platform. Togethe ...

Join the inaugural Bengaluru Skill Development Summit featuring global leaders, policymakers, and experts, focusing on Workforce 2030.

OneDigital’s AI-powered consultant, ‘Ben,’ is not just surfacing knowledge about employee benefits, but a collaborative equal ...

Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full ...

Redefine Properties Limited ( OTCPK:RDPEF) Q4 2025 Earnings Call November 3, 2025 6:00 AM EST ...

Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stagesDemons ...

November 2025 ? Theon International Plc (THEON) publishes its Q3 2025 Trading Update, along with its FY 2026 Revenue Target. Today, THEON increases FY 2025 revenue guidance to ...

Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor. Early data from the studies have demonstrated effects on hematologic malignancies and solid tumors. Lisaftoclax is ...

Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...